| Literature DB >> 30875679 |
Ilan Rahmani Tzvi-Ran1, Judith Olchowski1, Merav Fraenkel1, Asher Bashiri1, Leonid Barski1.
Abstract
A previously healthy 24-year-old female underwent an emergent caesarean section without a major bleeding described. During the first post-operative days (POD) she complained of fatigue, headache and a failure to lactate with no specific and conclusive findings on head CT. On the following days, fever rose with a suspicion of an obstetric surgery-related infection, again with no evidence to support the diagnosis. On POD5 a new-onset hyponatremia was documented. The urine analysis suggested SIADH, and following a treatment failure, further investigation was performed and demonstrated both central hypothyroidism and adrenal insufficiency. The patient was immediately treated with hydrocortisone followed by levothyroxine with a rapid resolution of symptoms and hyponatremia. Further laboratory investigation demonstrated anterior hypopituitarism. The main differential diagnosis was Sheehan's syndrome vs lymphocytic hypophysitis. Brain MRI was performed as soon as it was available and findings consistent with Sheehan's syndrome confirmed the diagnosis. Lifelong hormonal replacement therapy was initiated. Further complaints on polyuria and polydipsia have led to a water deprivation testing and the diagnosis of partial central insipidus and appropriate treatment with DDAVP. Learning points: Sheehan's syndrome can occur, though rarely, without an obvious major post-partum hemorrhage. The syndrome may resemble lymphocytic hypophysitis clinically and imaging studies may be crucial in order to differentiate both conditions. Hypopituitarism presentation may be variable and depends on the specific hormone deficit. Euvolemic hyponatremia workup must include thyroid function test and 08:00 AM cortisol levels.Entities:
Keywords: 2019; ACTH stimulation; Adrenal; Adrenal insufficiency; Antidiuretic Hormone; CT scan; Caesarean section; Cortisol; Desmopressin; Diabetes insipidus; Diabetes insipidus - neurogenic/central; Emergency; FSH; FT3; FT4; Fatigue; Female; Fluid restriction; Furosemide; GH; Glucocorticoids; Haemoglobin ; Headache; Hormone replacement; Hydrocortisone; Hyponatraemia; Hypopituitarism; Hypothyroidism; IGF1; Israel; LH; Levothyroxine; MRI; March; Oestradiol (E2); Other; Pituitary; Polydipsia; Polyuria; Potassium; Pregnant adult; Pyrexia; SIADH; Saline; Salt supplements; Sheehan's syndrome; Sodium; TSH; Thyroid; Thyroid function; Thyroxine (T4); Triiodothyronine (T3); Unique/unexpected symptoms or presentations of a disease; Urinalysis; Urine osmolality
Year: 2019 PMID: 30875679 PMCID: PMC6432973 DOI: 10.1530/EDM-18-0124
Source DB: PubMed Journal: Endocrinol Diabetes Metab Case Rep ISSN: 2052-0573
Comparison of Sheehan’s syndrome case reports resulting in acute hyponatremia.
| First author | Blood loss (L) | Shock (yes/no) | Clinical manifestation |
|---|---|---|---|
| Putterman ( | 2 | Yes | Paresthesia |
| Boulanger ( | Not described | Not described | Asthenia |
| Schrager ( | Not described (severe) | Yes | Fatigue |
| Lust ( | 3.2 | Yes | Headache |
| Bunch ( | Massive | Yes | Headache |
| Kaplun J ( | Massive | Yes | Headache, fever |
| Anfuso ( | 0.5 | No | Asthenia, headache |
| Matsuzaki ( | 5 | Yes | Convulsion, coma |
| Current case | 1 | No | Fever, headache, fatigue |
Patient’s relevant blood tests during pregnancy and presentation.
| Parameters | Pregnancy age | |||
|---|---|---|---|---|
| 8 weeks | 25 weeks | 39 weeks (POD2) | POD11 | |
| Hb (g/dL) | 13 | 9.4 | 7.8 | 7.5 |
| Na (mEq/L) | 138 | – | 148 | 117 |
| K (mEq/L) | 4 | – | 4.1 | 5.1 |
| TSH (uIU/mL) | 2.49 | 2.1 | – | 0.12 |
| Free T3 (pg/mL) | – | – | – | 1.8 |
| Free T4 (pg/mL) | – | – | – | 0.6 |
Blood hormone levels on POD5.
| Hormones | Values |
|---|---|
| TSH | 0.12 uU/L (0.39–4) |
| FT3 | 1.8 pg/dL (2.3–4.2) |
| FT4 | 0.6 pg/dL (0.8–1.5) |
| Cortisol (08:00 AM) | <0.6 ug/dL |
| Cortisol after ACTH stimulation administration | 5.26 ug/dL |
| Prolactin | 7 ng/mL (1–29)* |
| LH | <0.2 IU/L¶ |
| FSH | 0.4 IU/L¶ |
| Estradiol | <21 pg/mL¶ |
| Growth hormone | <0.05 ng/mL (0–5) |
| IGF-1 | 75 µg/L (102–317) |
*Normal range to a non-pregnant non-lactating female; ¶all measurements are below minimal values regardless to the timing during the menstrual period.
FSH, follicular-stimulating hormone; IGF-1, insulin-like growth factor 1; LH, luteinizing hormone; TSH, thyroid-stimulating hormone.
Figure 1Patients’ brain MRI.
Figure 2Patients’ brain MRI.